Hartmut Jaeschke

Dr. Jaeschke joined the University of Kansas Medical Center in 2006 from the University of Arizona College of Medicine. He previously held positions at University of Arkansas and Baylor University. In addition to his teaching and research positions at KU Medical Center, Dr. Jaeschke served as Chair of the Department of Pharmacology, Toxicology, and Therapeutics from 2012-2024. He is a Fellow of the Academy of Toxicological Sciences (ATS) and Fellow of the American Association for the Study of Liver Diseases (FAASLD).

In addition to his work in higher education, Dr. Jaeschke spent six years in the pharmaceutical industry with The Upjohn Co. and Pharmacia. He has published more than 520 peer-reviewed manuscripts, invited reviews, and book chapters in the areas of liver toxicology and liver pathophysiology. In 2019, he was the recipient of the Translational Impact Award from the Society of Toxicology. His major research interests include basic mechanisms and translational aspects of xenobiotic-induced hepatotoxicity and tissue repair with focus on acetaminophen overdose and mechanisms of inflammatory liver injury in animal models and humans.

Learn more about Hartmut Jaeschke on the KU Medical Center website.